Addus HomeCare Co. (NASDAQ:ADUS) Receives $103.00 Average Price Target from Brokerages

Addus HomeCare Co. (NASDAQ:ADUS) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $103.00.

Several equities research analysts recently commented on the company. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research report on Monday, February 5th. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a research report on Tuesday, April 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 target price on shares of Addus HomeCare in a research report on Thursday, February 29th. Finally, Oppenheimer reissued an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research note on Tuesday, March 26th.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in ADUS. Exchange Traded Concepts LLC increased its holdings in Addus HomeCare by 0.8% during the 4th quarter. Exchange Traded Concepts LLC now owns 14,310 shares of the company’s stock worth $1,329,000 after purchasing an additional 113 shares in the last quarter. Guinness Asset Management LTD grew its holdings in Addus HomeCare by 2.7% during the third quarter. Guinness Asset Management LTD now owns 5,267 shares of the company’s stock worth $449,000 after buying an additional 137 shares in the last quarter. GAMMA Investing LLC lifted its stake in Addus HomeCare by 40.8% during the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock valued at $57,000 after acquiring an additional 161 shares in the last quarter. Sheets Smith Wealth Management boosted its holdings in Addus HomeCare by 2.5% during the 3rd quarter. Sheets Smith Wealth Management now owns 6,892 shares of the company’s stock worth $587,000 after acquiring an additional 168 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in Addus HomeCare by 17.1% during the 3rd quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after acquiring an additional 194 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Stock Up 3.1 %

Shares of NASDAQ ADUS opened at $94.54 on Friday. Addus HomeCare has a 52-week low of $77.30 and a 52-week high of $114.97. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The company’s 50 day moving average price is $97.69 and its 200-day moving average price is $91.79. The company has a market capitalization of $1.55 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 1.86 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.17. The business had revenue of $276.35 million for the quarter, compared to analyst estimates of $274.02 million. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. Equities analysts forecast that Addus HomeCare will post 4.38 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.